Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Mol Cell Cardiol. 2011 Oct 20;52(3):701–710. doi: 10.1016/j.yjmcc.2011.10.010

Table 2.

Diastolic Echocardiogram parameters

WT PGC-1α−/− Ob/Ob Ob/Ob-PGC1α−/−
HR (slow) 426 ± 12 418 ± 7 421 ± 7 407 ± 6
E 0.809 ± 0.02 0.761 ± 0.03 0.959 ± 0.05* 0.921 ± 0.03*
A 0.745 ± 0.02 0.745 ± 0.03 0.919 ± 0.04* 0.894 ± 0.03*
E/A 1.09 ± 0.04 1.02 ± 0.01 1.04 ± 0.01 1.03 ± 0.01
E 0.050 ± 0.002 0.049 ± 0.002 0.046 ± 0.002 0.048 ± 0.001
S 0.045 ± 0.002 0.044 ± 0.001 0.041 ± 0.002 0.040 ± 0.001
E/E 16.4 ± 0.6 15.5 ± 0.6 21.1 ± 1.0* 19.2 ± 0.4*
IVCT 9.0 ± 0.3 9.4 ± 0.5 7.9 ± 0.1* 8.6 ± 0.3*
ET 36.1 ± 0.8 34.2 ± 1.3 38.8 ± 1.7 35.8 ± 1.4
IVRT 13.5 ± 0.4 12.5 ± 0.4 12.3 ± 0.5 13.4 ± 0.4

HR (slow) = heart rate after Zatabradine, E = Peak trans-mitral E velocity (mm/sec), A = Peak trans-mitral A velocity (mm/sec), S′ = peak systolic mitral annular velocity (mm/sec), E′ = peak early diastolic mitral annular velocity (mm/sec), A′ = peak late (atrial) mitral annular velocity (mm/sec), IVCT = isovolumic contraction time (msec), ET = ejection time (msec), IVRT = isovolumic relaxation time (msec). p < 0.05 vs WT,

p < 0.05 vs PGC-1α−/−,

¥

p < 0.05 vs Ob/Ob.